These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28135234)

  • 1. Fresh from the biotech pipeline-2016.
    Morrison C
    Nat Biotechnol; 2017 Feb; 35(2):108-112. PubMed ID: 28135234
    [No Abstract]   [Full Text] [Related]  

  • 2. Fresh from the biotech pipeline--2013.
    Kling J
    Nat Biotechnol; 2014 Feb; 32(2):121-4. PubMed ID: 24509747
    [No Abstract]   [Full Text] [Related]  

  • 3. Fresh from the biotech pipeline-2018.
    Morrison C
    Nat Biotechnol; 2019 Feb; 37(2):118-123. PubMed ID: 30718867
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech innovators jump on biosimilars bandwagon.
    Moran N
    Nat Biotechnol; 2012 Apr; 30(4):297-9. PubMed ID: 22491261
    [No Abstract]   [Full Text] [Related]  

  • 5. The Biosimilar Pipeline Seams Seem To Be Bursting.
    Reinke T
    Manag Care; 2017 Mar; 26(3):24-25. PubMed ID: 28510516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fresh from the biotech pipeline--2015.
    Morrison C
    Nat Biotechnol; 2016 Feb; 34(2):129-32. PubMed ID: 26849511
    [No Abstract]   [Full Text] [Related]  

  • 7. The year's new drugs & biologics, 2013: Part II.
    Graul AI; Navarro D; Dulsat C; Cruces E; Tracy M
    Drugs Today (Barc); 2014 Feb; 50(2):133-58. PubMed ID: 24619590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fresh from the biotech pipeline: too much, too fast?
    Senior M
    Nat Biotechnol; 2022 Feb; 40(2):155-162. PubMed ID: 35102293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encouraging guidance released for biosimilar manufacturers.
    Reinke T
    Manag Care; 2014 Aug; 23(8):10, 13. PubMed ID: 25225711
    [No Abstract]   [Full Text] [Related]  

  • 10. Biopharmaceutical benchmarks 2018.
    Walsh G
    Nat Biotechnol; 2018 Dec; 36(12):1136-1145. PubMed ID: 30520869
    [No Abstract]   [Full Text] [Related]  

  • 11. First US biosimilar edges towards market.
    Senior M
    Nat Biotechnol; 2015 Mar; 33(3):222-3. PubMed ID: 25748898
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosimilars: what's in a name?
    Silverman E
    BMJ; 2014 Jan; 348():g272. PubMed ID: 24443479
    [No Abstract]   [Full Text] [Related]  

  • 13. First biosimilar drug approved for sale in the United States.
    Hede K
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142444
    [No Abstract]   [Full Text] [Related]  

  • 14. Indiana jumps the biosimilars gun.
    Fox JL
    Nat Biotechnol; 2014 May; 32(5):406. PubMed ID: 24811502
    [No Abstract]   [Full Text] [Related]  

  • 15. Fresh from the biotech pipeline-2014.
    Morrison C
    Nat Biotechnol; 2015 Feb; 33(2):125-8. PubMed ID: 25658270
    [No Abstract]   [Full Text] [Related]  

  • 16. The constrained prescription, interchangeability and substitution of biosimilars.
    Minghetti P; Rocco P; Schellekens H
    Nat Biotechnol; 2015 Jul; 33(7):688-9. PubMed ID: 26154003
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction and commentary: Paving the way for biosimilars in oncology, part 3: Clinical and economic impact of oncology biosimilars.
    Abraham J
    Semin Oncol; 2014 Apr; 41 Suppl 3():S1-2. PubMed ID: 24767631
    [No Abstract]   [Full Text] [Related]  

  • 18. 25 breakout companies--biotech: Sirtris Pharmaceuticals, Bacterin, XDX.
    Stipp D; Boyle M; Stires D
    Fortune; 2005 May; 151(10):169. PubMed ID: 15931765
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug Development. Are trade secrets delaying biosimilars?
    Price WN; Rai AK
    Science; 2015 Apr; 348(6231):188-9. PubMed ID: 25859034
    [No Abstract]   [Full Text] [Related]  

  • 20. First biosimilar drug set to enter US market.
    Ledford H
    Nature; 2015 Jan; 517(7534):253-4. PubMed ID: 25592512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.